Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | KIT |
Variant | K642E |
Impact List | missense |
Protein Effect | gain of function |
Gene Variant Descriptions | KIT K642E lies within the tyrosine kinase domain 1 (exon 13) of the Kit protein (PMID: 15990278). K642E results in constitutive phosphorylation of Kit and activation of downstream signaling (PMID: 15990278, PMID: 19802003), as well as transformation of cultured cells (PMID: 11073817). |
Associated Drug Resistance | |
Category Variants Paths |
KIT mutant KIT act mut KIT K642E KIT mutant KIT exon13 KIT K642E |
Transcript | NM_000222.3 |
gDNA | chr4:g.54728055A>G |
cDNA | c.1924A>G |
Protein | p.K642E |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_000222.2 | chr4:g.54728055A>G | c.1924A>G | p.K642E | RefSeq | GRCh38/hg38 |
NM_000222.3 | chr4:g.54728055A>G | c.1924A>G | p.K642E | RefSeq | GRCh38/hg38 |
NM_000222 | chr4:g.54728055A>G | c.1924A>G | p.K642E | RefSeq | GRCh38/hg38 |
NM_001385285.1 | chr4:g.54728055A>G | c.1924A>G | p.K642E | RefSeq | GRCh38/hg38 |
XM_017008178 | chr4:g.54728055A>G | c.1924A>G | p.K642E | RefSeq | GRCh38/hg38 |
XM_017008178.1 | chr4:g.54728055A>G | c.1924A>G | p.K642E | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05554341 | Phase II | Nilotinib + Paclitaxel | Testing the Use of Nilotinib and Paclitaxel as a Treatment for Patients With Prior Taxane Treatment, A ComboMATCH Treatment Trial | Suspended | USA | 0 |